Detalles de la búsqueda
1.
Optimization of dose and route of administration of the P-glycoprotein inhibitor, valspodar (PSC-833) and the P-glycoprotein and breast cancer resistance protein dual-inhibitor, elacridar (GF120918) as dual infusion in rats.
Pharmacol Res Perspect
; 9(2): e00740, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33660938
Resultados
1 -
1
de 1
1
Próxima >
>>